The Eurocine® L3 adjuvants with subunit influenza antigens induce protective immunity in mice after intranasal vaccination
Authors:
- Åke LundkvistÅLÅke Lundkvist
- 1 September 2010
- Vol. 28 (39) , 6491-6497
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile ToxinPLOS ONE, 2009
- Intranasal Vaccination with 1918 Influenza Virus-Like Particles Protects Mice and Ferrets from Lethal 1918 and H5N1 Influenza Virus ChallengeJournal of Virology, 2009
- Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: Effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge modelVaccine, 2008
- Cross‐Protection against H5N1 Influenza Virus Infection Is Afforded by Intranasal Inoculation with Seasonal Trivalent Inactivated Influenza VaccineThe Journal of Infectious Diseases, 2007
- Induction of secretory immunity and memory at mucosal surfacesVaccine, 2007
- A global pandemic influenza vaccine action planVaccine, 2006
- A novel DNA adjuvant, N3, enhances mucosal and systemic immune responses induced by HIV-1 DNA and peptide immunizationsVaccine, 2005
- Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in miceVaccine, 2003
- Novel generations of influenza vaccinesVaccine, 2003
- Nasal and parenteral immunizations with diphtheria toxoid using monoglyceride/fatty acid lipid suspensions as adjuvantsVaccine, 1999